FIRST AMENDMENT TO CONFIDENTIALITY AGREEMENTConfidentiality Agreement • March 24th, 2023 • Sanofi • Pharmaceutical preparations
This First Amendment to Confidentiality Agreement (the “First Amendment”) is made and entered into as of December 07th, 2022 (the “First Amendment Effective Date”) by and between:
Subject: Exclusivity AgreementExclusivity Agreement • March 24th, 2023 • Sanofi • Pharmaceutical preparations
In connection with the consideration by Sanofi and/or certain of its affiliates (“Sanofi”) of a possible negotiated transaction between Sanofi and Provention Bio, Inc. (the “Company” and, such potential transaction, the “Proposed Transaction”), Sanofi and the Company are entering into this letter agreement to induce Sanofi to devote the resources to investigate, negotiate and enter into a definitive agreement with respect to the Proposed Transaction.
February 26, 2023Confidentiality Agreement • March 24th, 2023 • Sanofi • Pharmaceutical preparations
In connection with Sanofi’s (“you” or “your”) interest in a possible negotiated transaction (the “Possible Transaction”) with Provention Bio, Inc. a Delaware corporation (the “Company”), you have requested that the Company or the Company Representatives (as defined below) furnish you or your Representatives (as defined below) with certain information relating to the Company, its subsidiaries, divisions, affiliates or the Possible Transaction. As a condition to such information being furnished or made available to you and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, you and the Company hereby agree as follows.
CONFIDENTIALITY AGREEMENTConfidentiality Agreement • March 24th, 2023 • Sanofi • Pharmaceutical preparations • New York
WHEREAS Sanofi and Provention have entered into non-confidential discussions regarding a potential business transaction involving the parties (the “Potential Transaction”);
